Search Results (1,743)

This study examined the impact of three pre-season fitness training protocols with different training frequencies (heavy, moderate and light) on the physical abilities and the biochemical indicators of muscle damage and oxidative stress in female basketball athletes as expressed through physiological and biochemical assessments. Also, a comparison and a search for correlations were made between the physiological and biochemical changes that were caused by each protocol. The sample consisted of 28 professional female basketball athletes, who competed in three different teams, and each training protocol was assigned to each of the three teams. The somatometric and performance markers measured were as follows: weight, fat percentage, aerobic capacity, anaerobic capacity, vertical jumping ability, speed, acceleration, explosiveness and maximum lower body part strength. The biochemical measurements consisted of exercise-induced muscle damage (creatine kinase—CK, lactate dehydrogenase—LDH) and oxidative stress markers (protein carbonyls—PCs, glutathione peroxidase—GPx). The three fitness training protocols that were used improved the fitness status of high-level female basketball athletes after 6 weeks during the pre-season period, but they were also accompanied by some significant differences between them (fat percentage, anaerobic capacity, speed and acceleration). The results were also accompanied by an increase in CK and LDH for the three teams and by an increase in GPx for Teams 1 and 3. Also, we concluded that even 4 more or 4 less fitness training units (TUs) during a 6-week basketball preparation period can be considered important to differentiate the outcomes of physiological and biochemical markers. The purpose of this study was to provide more theoretical and practical knowledge to basketball coaches and trainers, so they can optimize the training process during the preparation period and thus maximize the performance of their athletes. Nevertheless, the present study was created with certain limitations, such as the small sample size for each team, the absence of a long-term follow-up or the lack of a control group. Future studies may need to turn their focus on fitness protocols with longer durations, try to differentiate the types of training protocols and attempt to achieve a better balance between maximizing performance and mitigating the muscle damage and oxidative stress levels. Full article

This review comprehensively compares lymphoma in humans and dogs, highlighting the canine model’s utility in translational research. Canine lymphoma (cL), predominantly diffuse large B-cell lymphoma (DLBCL), mirrors human non-Hodgkin’s lymphoma (NHL) in its clinical presentation, including lymphadenopathy, systemic symptoms (e.g., fever, weight loss), and hematological abnormalities. Morphologically, cL and NHL share similarities in DLBCL subtypes (centroblastic, immunoblastic, anaplastic), although some variations exist, such as the presence of macronuclear medium-sized cells in canine polymorphonuclear centroblastic lymphoma, not observed in humans. Canine and human lymphomas share molecular mechanisms, including the activation of key pathways like NF-κB and mTOR, and genetic and epigenetic alterations. The tumor microenvironment influences tumor growth and immune evasion in both species. Both species exhibit similar responses to chemotherapy, primarily CHOP-based protocols, although canine lymphoma often progresses more rapidly, offering advantages for shorter clinical trials. Molecular targeted therapy is emerging as a promising treatment, with human therapies like rituximab and chimeric antigen receptor T-cell therapy showing efficacy, and canine treatments still developing. Epidemiological data reveal overlapping risk factors, including exposure to environmental carcinogens (e.g., household chemicals, pollution) and the potential influence of sex hormones, although the role of sex hormones requires further investigation in canines. While staging systems differ slightly (Lugano modification of Ann Arbor for humans, WHO system for dogs), both consider disease extent and systemic involvement. Prognostic factors, such as lactate dehydrogenase (LDH) levels, are relevant in human NHL but have not shown consistent utility in cL. This study concludes that the spontaneous development of cL in immunocompetent dogs, coupled with its clinical, histological, and therapeutic similarities to human NHL, makes the canine model invaluable for preclinical research, accelerating the development of novel diagnostic tools and therapies for both human and canine lymphoma. The shared environmental risk factors and shorter disease progression in dogs further enhance the translational potential of this model, promoting a One Health approach to cancer research. Full article

Water treadmill (WT) exercise is gaining popularity among equine athletes as it allows for increased workload through the resistance posed by water. However, the effect of an artificial river (AR), which further increases this resistance, on equine fitness indicators has not yet been investigated. This study aimed to determine whether WT exercise with varying water depths and the presence of an AR influences physiological response indicators. Fifteen school horses (n = 15) underwent five treadmill exercise sessions: on a dry treadmill (DT), in fetlock-depth water with and without AR, and in carpal-depth water with and without AR. Physiological responses were assessed pre-exercise, during the highest workload, and at 30 min and 24 h post-exercise by measuring heart rate (HR), blood lactate concentration (LAC), red blood cell count (RBC), hemoglobin concentration (HGB), and the activity of three serum enzymes: creatine phosphokinase (CK), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH). HR and LAC increased significantly (p < 0.0001) from the pre-exercise resting state to the highest workload time point during treadmill exercise, regardless of session type. During the carpal-depth WT+AR session, horses achieved a fitness level characterized by the highest HR (p < 0.0001), LAC (p < 0.0001), and LDH activity (p = 0.001). Thus, horses’ physiological responses to walking on a WT with AR differ from those observed on a DT and a WT without AR. WT exercise with AR represents a low-to-moderate intensity aerobic workload for horses, which increases with water depth from fetlock to carpal levels. However, further research is required to evaluate its inclusion in training or rehabilitation programs for athletic horses and its potential beneficial effects. Full article

Background: The aim of this study was the determination of reference values for the common laboratory parameters in early pregnancy using a direct method and to assess their clinically significant difference, which was compared to the reference intervals for non-pregnant women with respect to the reference change value (RCV). Methods: This study was conducted from September 2022 to December 2023 at the Clinical Department of Laboratory Diagnostics, Clinical Hospital Centre RIJEKA, Croatia. The inclusion criteria were as follows: age ≥ 18 years, singleton pregnancy, normal ultrasound examination, and prenatal screening. The exclusion criteria were as follows: recent illness, pregnancy-related complications, medically assisted reproduction, and medication use. The reference intervals were established using the non-parametric percentile method according to the CLSI EP28-A3c recommendation. The reference values were compared to those of non-pregnant women and judged against RCV values based on biological variation. Additionally, we tested the influence of food consumption and oral supplements. Results: The data of 299 participants were included in the study. Laboratory tests whose changes are clinically relevant lower in early pregnancy are as follows: hemoglobin, MCV, hematocrit, MCH, urea, creatinine, albumin, alkaline phosphatase, lactate dehydrogenase, sodium, and magnesium. The clinically relevant higher values are as follows: RDW, total leukocyte count, neutrophil granulocytes, monocytes, CRP, total cholesterol, triglycerides, and amylase. UIBC has a wider reference range. The consumption of food and supplements has no clinically significant influence in relation to the RCV. Conclusions: Establishing reference intervals in pregnancy remains a challenge due to the metabolic changes during pregnancy, as well as its clinical significance. Full article

Metformin is the first-line medication for treating type 2 diabetes mellitus, with more than 200 million patients taking it daily. Its effects are extensive and play a positive role in multiple areas. Can its effects and potential mechanisms be explored through the urine proteome? In this study, 166 differential proteins were identified following the administration of 150 mg/(kg·d) of metformin to rats for five consecutive days. These included complement component C6, pyruvate kinase, coagulation factor X, growth differentiation factor 15, carboxypeptidase A4, chymotrypsin-like elastase family member 1, and L-lactate dehydrogenase C chain. Several of these proteins have been reported to be directly affected by metformin or associated with its effects. Multiple biological pathways enriched by these differential proteins, or proteins containing differentially modified peptides, have been reported to be associated with metformin, such as the glutathione metabolic process, negative regulation of gluconeogenesis, and the renin–angiotensin system. Additionally, some significantly changed proteins and enriched biological pathways, not yet reported to be associated with metformin’s effects, may provide clues for exploring its potential mechanisms. In conclusion, the application of the urine proteome offers a comprehensive and systematic approach to exploring the effects of drugs, providing a new perspective on the study of metformin’s mechanisms. Full article

The aim of the present study was to investigate the dietary effects of replacing corn with different proportions of fermented straw on the growth performance and intestinal health of finishing pigs. A total of 275 healthy commercial finishing pigs aged 126 days (average body weight, 82.96 ± 3.07 kg) were randomly allocated into three groups: the control (CTR, basal diet) group, the 5% fermented straw (FJJG5, replacing 5% of the corn) group, and the 10% fermented straw (FJJG10, replacing 10% of the corn) group. There were six replicates in each group and 14–16 pigs per replicate. On day 39 of the experiment, one animal from each replicate was slaughtered for sampling and for further analysis. The results showed that the finishing pigs in the FJJG10 group had a reduced average daily weight gain and an increased feed-to-gain ratio. The FJJG5 group had reduced total cholesterol, high-density lipoprotein, and low-density lipoprotein in their serum, while the FJJG5 and FJJG10 groups had reduced contents of lactate dehydrogenase. In addition, the FJJG5 group exhibited increased T-SOD activity and MDA content in the colon, while the FJJG10 group also showed increased T-AOC activity in their serum and increased contents of MDA in the colon. The FJJG5 group exhibited increased activities of jejunal disaccharidase and lipase, while the FJJG10 group exhibited decreased jejunal crypt depths. Moreover, the FJJG5 group presented an increased relative expression of APOA4, LPL, and MUC2 but decreased SLC7A7 and IL-10 in the jejunum and APOA4 in the colon. The FJJG10 group exhibited a decreased relative expression of SLC7A7 and IL-10 in the jejunum and decreased MMP13, KCNJ13, APOA4, SLC7A7, LPL, and IL-10 in the colon. Furthermore, the FJJG5 group exhibited an increased relative abundance of Lactobacillus in colon contents, while the FJJG10 group had a reduced relative abundance of streptococcus. In conclusion, 5% fermented straw can improve the lipid metabolism and colon microbiota structure of finishing pigs, while 10% fermented straw has adverse effects on the growth performance and intestinal health of finishing pigs. Full article

Background/Objectives: To investigate the value of intestinal fatty acid-binding protein (I-FABP), D-Lactate, interleukin-6 (IL-6), interleukin-10 (IL-10), interleukin-1 receptor antagonist (IL-1Ra), tumor necrosis factor-alpha (TNF-alpha), lactate dehydrogenase (LDH), alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatine kinase (CK), electrolytes and creatinine in athletes with lower gastrointestinal symptoms in a cohort of ultra-trailers. Methods: This is a prospective study set in the ultra-trail of Puy Mary Aurillac, a 105 km race. Athletes included were given two questionnaires to collect demographic data and clinical signs related to the race. Blood samples were also collected before and 1 h after the race. Biomarker results were interpreted according to the occurrence of exercise-induced lower gastrointestinal symptoms, and whether the race was completed or forfeited. Results: Of the 76 runners included, 35 (45.5%) presented lower gastrointestinal symptoms. Runners that presented these symptoms had significantly higher IL-10 concentrations (8.7 pg/mL (interquartile range (IQR): 4.2–1.6)) when compared to runners without symptoms (4.8 pg/mL (IQR: 2.4–9)) (p = 0.01). The pre/post-race amplitude of IL-1Ra variation was greater in the group of runners with lower gastrointestinal symptoms (median: +231% (IQR: 169–551)) compared to runners without symptoms (median: +172% (IQR: 91–393)) (p = 0.04). Finally, the 13 (16.9%) runners who forfeited the race displayed lower AST (p < 0.001), LDH (p = 0.002) and IL-6 (p = 0.002) concentrations, compared to runners who finished the race. These lower concentrations were independent from running time. Conclusions: IL-10 and IL-1Ra could be associated with the occurrence of lower gastrointestinal symptoms. Full article

Background: Medical history, ECG findings and cardiac markers are used in the diagnosis of myocardial infarction (MI). Biomarkers used especially for the diagnosis of MI include high-sensitivity troponins (hsTns), creatine kinase-MB (CK-MB), lactate dehydrogenase (LDH), myoglobin, cardiac myosin-binding protein C and new cardiac biomarkers. This study evaluated the levels of serum thrombomodulin (TM), heart-type fatty-acid-binding protein (H-FABP), pentraxin-3 (PTX-3) and galectin-3 (Gal-3) to determine their utility in distinguishing between ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI). Methods: This study included a total of 180 patients (90 patients with acute STEMI and 90 patients with NSTEMI) who presented to the Gaziosmanpaşa Training and Research Hospital, Cardiovascular Surgery and Emergency Department, with ischemic chest pain lasting longer than 30 min. Ninety healthy volunteers were included as the control group. Results: Serum levels of N-terminal pro-brain natriuretic peptide (NT-proBNP), TM, H-FABP, PTX-3 and Gal-3 were significantly different across the STEMI, NSTEMI and control groups (p < 0.001). Strong positive correlations were observed between NT-proBNP and TM, H-FABP, PTX-3 and Gal-3 in the STEMI group. ROC analysis demonstrated excellent diagnostic accuracy for these biomarkers in distinguishing STEMI from NSTEMI and control groups. Conclusions: Vascular inflammation plays an important role in the pathophysiology of STEMI and NSTEMI. A comprehensive cardiac biomarker panel enhances diagnostic accuracy and risk stratification, particularly when distinguishing between STEMI and NSTEMI. The biomarkers hs-TnI, CK-MB, NT-proBNP, TM, H-FABP, PTX-3 and Gal-3 offer complementary information when used together as a panel. Further research and validation are essential to establish standardized protocols for their widespread use. Full article

This study presents findings from two discrete experimental processes that examined the impact of lameness events on two consecutive, critical time points in the annual production cycle of dairy cattle (early in puerperium—first study, and later at the onset of the reproductive period—second study) regarding liver function, glucose levels, milk production, body condition score, and back fat thickness. In the first study, 47 cows (lame group n = 22, control group n = 25) were monitored from 10 days ante partum (ap) to 46 days post-partum (pp). In the second study, 79 cows (lame group n = 52, control group n = 27) were monitored from day 28 ± 5 pp to day 65–72 ± 5 pp. Lame cows had greater gamma-glutamyl transferase (GGT) concentrations in the blood serum compared to control cows (25.83 vs. 23.56, p = 0.02, respectively) early in puerperium, whereas the two groups did not differ in the second study. The concentration of glutamate dehydrogenase (GLDH) was lower for lame compared to control cows in both studies (17.24 vs. 24.60, respectively, p = 0.02 in the first study, and 30.50 vs. 51.10, respectively, p = 0.02 in the second study). The concentrations of aspartate transaminase (AST) and glucose did not differ between groups in both studies. Lame cows had a lower body condition score (BCS) and backfat thickness (BFT) scores compared to the control in both studies overall. The lame cows of the first study experienced a significant loss of milk production, especially during the second month of lactation, while in the second study, milk production remained unaffected. Conclusively, lame cows have lower BCS and BFT values, whereas milk yield can be negatively affected only if lameness occurs early in the puerperium, probably beginning at the dry period. However, the current research shows that acutely lame cows, as described in this study, exhibit only mild alterations in liver function compared to non-lame ones. Full article

This study aimed to evaluate the effects of the water-soluble fraction of crude oil (WSFO) on Indian carp (Labeo rohita) with and without treatment with zinc oxide nanoparticles (Nano-ZnO). A total of 225 fish were randomly assigned to five groups in triplicate for 21 days. Group I served as the control group. Groups II and III were exposed to 0.5% and 1% untreated WSFO, respectively. Groups IV and V received 5% and 10% WSFO treated with Nano-ZnO, while Groups VI and VII received 5% and 10% WSFO treated without Nano-ZnO. No blood samples were obtained from fish exposed to untreated WSFO, due to increased hemolysis. Exposure to treated WSFO increased creatine phosphokinase, alkaline phosphatase, aspartate aminotransferase, lactate dehydrogenase, and gamma-glutamyl transferase activities, while alanine aminotransferase activity decreased. Although a significant decrease was observed in total protein, globulin, and triglyceride levels, albumin and cholesterol increased. Thiol groups and glutathione peroxidase activity significantly decreased, while superoxide dismutase, catalase, total antioxidant capacity, and malondialdehyde levels increased. The findings showed that exposure to WSFO, whether treated or untreated, induces significant biochemical and oxidative stress responses in Labeo rohita. Although WSFO treated with Nano-ZnO mitigated hemolysis, it was unable to prevent enzyme and antioxidant imbalances, indicating persistent physiological stress. Full article

This study investigated the diagnostic, prognostic, and therapeutic significance of Fc receptor-like 1 (FCRL1) and B-cell activating factor (BAFF) mRNA expression in Egyptian patients with diffuse large B-cell lymphoma (DLBCL) undergoing the standard R-CHOP regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) using quantitative real-time PCR (RT-qPCR). The results demonstrated that FCRL1 and BAFF mRNA expression were significantly elevated in DLBCL patients compared to healthy controls. A strong positive correlation existed between BAFF and FCRL1 expression levels. Diagnostic performance assessed through combined ROC curve analysis revealed that BAFF, FCRL1, and lactate dehydrogenase (LDH) achieved perfect diagnostic accuracy (AUC = 1.0), demonstrating 100% sensitivity, specificity, and predictive values. Further prognostic analysis using COX regression identified elevated FCRL1 expression as the most significant predictor of poor clinical outcomes. Kaplan–Meier survival analysis reinforced this finding, with high FCRL1 expression showing significant associations with reduced overall survival (OS, p = 0.031) and progression-free survival (PFS, p = 0.038). The study underscores the potential utility of BAFF and FCRL1 mRNA as diagnostic markers for DLBCL, with FCRL1 emerging as a promising prognostic marker and potential therapeutic target enabling more tailored treatment approaches for DLBCL, the most common type of B-cell non-Hodgkin lymphoma, and patients receiving R-CHOP therapy. Full article

Background/Objectives: The prognostic value of baseline clinical parameters in predicting the survival prolonging effect of Radium-223-dichloride (²²³RaCl₂) for metastatic castration resistant prostate cancer (mCRPC) patients has been the object of intensive research and remains an open issue. This national multicenter study aimed to corroborate the evidence of ten years of clinical experience with ²²³RaCl₂ by collecting data from eight Italian Nuclear Medicine Units. Methods: Data from 581 consecutive mCRPC patients treated with ²²³RaCl₂ were retrospectively analyzed. Several baseline variables relevant to the overall survival (OS) analysis were considered, including age, previous radical prostatectomy/radiotherapy, number of previous treatment lines, prior chemotherapy, Gleason score, presence of lymphoadenopaties, number of bone metastases, concomitant use of bisphosphonates/Denosumab, Eastern Cooperative Oncology Group Performance Status (ECOG-PS), as well as baseline values of hemoglobin (Hb), platelets, Total Alkaline Phosphatase (tALP), Lactate Dehydrogenase (LDH), and Prostate-Specific Antigen (PSA). Data were summarized using descriptive statistics, univariate analysis and multivariate analysis with the Cox model. Results: The median OS time was 14 months (95%CI 12–17 months). At univariate analysis age, the number of previous treatment lines, number of bone metastases, ECOG-PS, presence of lymphadenopathies at the time of enrollment, as well as baseline tALP, PSA, and Hb, were independently associated with OS. After multivariate analysis, the number of previous treatment lines (HR = 1.1670, CI = 1.0095–1.3491, p = 0.0368), the prior chemotherapy (HR = 0.6461, CI = 0.4372–0.9549, p = 0.0284), the presence of lymphadenopathies (HR = 1.5083, CI = 1.1210–2.0296, p = 0.0066), the number of bone metastases (HR = 0.6990, CI = 0.5416–0.9020, p = 0.0059), ECOG-PS (HR = 1.3551, CI = 1.1238–1.6339, p = 0.0015), and baseline values of tALP (HR = 1.0008, CI = 1.0003–1.0013, p = 0.0016) and PSA (HR = 1.0004, CI = 1.0002–1.0006, p = 0.0005) remained statistically significant. Conclusions: In the era of precision medicine and in the landscape of novel therapies for mCRPC, the prognostic stratification of patients undergoing ²²³RaCl₂ has a fundamental role for clinical decision-making, ranging from treatment choice to optimal sequencing and potential associations. This large Italian multicenter study corroborated the prognostic value of several variables, emerging from ten years of clinical experience with ²²³RaCl₂. Full article

Objective: To determine the impact of hypothyroidism on uterine glycogen accumulation during pregnancy. Methods: Non-pregnant and pregnant (days 5, 10, and 20) rabbits were grouped into control and methimazole (MMI) groups. In rabbits, serum concentrations of thyroxine (T4), triiodothyronine, glucose, insulin, progesterone, and estradiol were quantified. In uterine inter- and implantation sites, the glycogen content and expression of lactate dehydrogenase (LDH), GLUT4, and aromatase were quantified via Western blot. Fetuses’ characteristics at 20 days of pregnancy were analyzed. Two-way ANOVA was used to compare variables between groups. Results: Pregnancy reduced T4 concentrations but not T3. In virgin groups, MMI treatment significantly reduced the concentrations of T4 and T3 and increased the expression of GLUT4 and aromatase in the uterus compared to the control group. In pregnant groups, T4, T3, glucose, insulin, progesterone, and estradiol levels were similar between control and MMI-treated rabbits. Compared to controls, MMI treatment in pregnant rabbits (a) reduced GLUT4 expression on inter-implantation sites on day 5; (b) increased glycogen content on implantation sites but reduced GLUT4 expression on inter-and implantation sites on day 10; (c) increased glycogen content and LDH and aromatase expression but reduced GLUT4 on inter-implantation sites; and (d) increased glycogen content and the expression of LDH, GLUT4, and aromatase on day 20 on implantation sites. Moreover, the fetus characteristics were similar between groups. Conclusions: MMI-induced hypothyroidism is associated with changes in the uterine content of glycogen and the expression of LDH, GLUT4, and aromatase during pregnancy. Full article

Background: Cardiogenic shock (CS), characterized by inadequate tissue perfusion due to cardiac dysfunction, has a high mortality rate despite advances in treatment. Systemic inflammation and organ failure exacerbate the severity of CS. Extracorporeal hemadsorption techniques such as CytoSorb^® have been introduced to control inflammation. However, evidence of their efficacy, particularly in patients on various mechanical circulatory support (MCS) systems, remains limited. Methods: This retrospective study analyzed data from 129 CS patients treated with CytoSorb^® at the University Hospital of Marburg between August 2019 and December 2023. Those patients receiving MCS were grouped according to MCS type: (1) Impella, (2) VA-ECMO, and (3) ECMELLA. The hemodynamic parameters of circulatory support (e.g., MCS flow rates and vasoactive inotropic score, VIS) and laboratory and ventilation parameters were assessed 24 h before start of CytoSorb^® therapy (T1) and 24 h after completion of CytoSorb^® therapy (T2). Results: Of 129 CS patients (mean age: 64.7 ± 13.1 years), 103 (79.8%) received MCS. Comparing T1 and T2, there was a significant reduction in VIS in the entire cohort (T1: 38.0, T2: 16.3; p = 0.002), with a concomitant significant reduction in the level of MCS support in all subgroups, indicating successful weaning. Analysis of laboratory parameters showed significant reductions in lactate (T1: 2.1, T2: 1.3 mmol/L; p = 0.014), myoglobin (T1: 1549.0, T2: 618.0 µg/L; p < 0.01), lactate dehydrogenase (T1: 872.0, T2: 632.0 U/L; p = 0.048), and procalcitonin (T1: 2.9, T2: 1.6 µg/L; p < 0.001). However, a significant decrease in platelets (T1: 140.0, T2: 54.0 tsd/µL; p < 0.001) and albumin (T1: 25.0, T2: 22.0 g/dL; p < 0.001) was also documented. The median SOFA score of the entire cohort was 15.0 (IQR 12.0–16.0), predicting a mortality rate of >80%, which could be reduced to 60.5% in the present study. Conclusions: During CytoSorb^® therapy in CS, a significant reduction in VIS was demonstrated, resulting in improved organ perfusion. Therefore, the results of this study underline that CytoSorb^® therapy can be considered a useful “component” in the complex management of CS, especially when combined with MCS. To refine and optimize treatment strategies in CS, prospective studies are needed to better define the role of hemadsorption. Full article

Long non-coding RNAs (lncRNAs) play complex roles at multiple levels of gene regulation, thus modulating key cellular processes involved in the pathogenesis and progression of cancer. Aberrant expression of lncRNAs has been reported in various malignancies, including chronic lymphocytic leukemia (CLL). We investigated the expression of lnc-IRF2-3 and lnc-KIAA1755-4 in peripheral blood mononuclear cells of 112 previously untreated CLL patients by quantitative reverse-transcriptase polymerase chain reaction. Both lncRNAs were found to be overexpressed in CLL samples in comparison to healthy controls, and their high levels were associated with adverse clinico-biological characteristics of patients at diagnosis. High lnc-IRF2-3 expression was associated with high leukocyte and lymphocyte counts, high β2-microglobulin, advanced Binet stage, unfavorable cytogenetics, CD38-positivity and IGHV-unmutated status. Regarding lnc-KIAA1755-4, its high expression was associated with high leukocyte count, lymphocyte count, β2-microglobulin, lactate dehydrogenase and low hemoglobin, as well as with IGHV-unmutated status. In addition, we observed shorter time to first treatment and overall survival of patients expressing high levels of both lncRNAs in comparison to low-expressing patients. In summary, our study showed that high lnc-IRF2-3 and lnc-KIAA1755-4 expression at diagnosis predicts poor survival in CLL. The mechanisms of their upregulation, as well as their specific targets in CLL cells, remain to be elucidated. Full article